. Also took placement stock @$1. ASX - Day TradingI bought some today at 44. Market . Created with Sketch. Created with Sketch. . 0. Appendix 4E and Annual Report, page-3. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. 0¢ Sentiment: Buy Disclosure: Held. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. ASX. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. ASX - By Stock. View daily, weekly or monthly formats back to when Invex Therapeutics Ltd stock was issued. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. $100-200k might be the minimum for the market to take notice. 0% $ODM 35. Been. 4. The company can always acquire something new or do some capital returns. A neurosurgeon from Mercer Island and a noted mountaineer from Spokane, Washington, were killed on February 4, 1986, when. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. Last updated 10. Created with Sketch. ASX - Day TradingAnother day…another approval. They have acted appropriately. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Latest Posts. Anyone buying now can carry to $5 and then sell a few prior to readout as insurance against losing everything in the coin flip. . ASX - By Stock. Market . Created with Sketch. 2. ASX - By Stock. Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Target our investor community with our suite of Hotcopper Advertising opportunities. I find this very intriguing and positive that in last few weeks about 1. All IMO IXC Price at posting: 37. June 23 (Reuters) - Invex Therapeutics Ltd (IXC) : GRANTING OF ORPHAN DRUG DESIGNATION FOR EXENATIDE IN TREATMENT OF MODERATE TO SEVERE TRAUMATIC BRAIN. 0 Great. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. Both approaches can work, but it is not wise to confuse the two. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Grabbed my first ever parcel in IXC yesterdy at 80c. . ASX - By Stock. ASX - By Stock. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. IXC Valuation Report MST. AX stock on Yahoo Finance. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. . ASX - By Stock. 19 Per share (Personal Estimate) vs MST Research report of $3. Join the HotCopper ASX share market forum today for free. Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. Notification of cessation of securities - IXC. Market . , page-3. Join the HotCopper ASX share market forum today for free. 1. 76 (-1. 40 in May 2020 and has only fallen over the subsequent 36 months. 1. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. International Markets. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Join the HotCopper ASX share market. ASX - Short Term Trading. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Forums. 26 area could be wrong and it could go for example to $3. Latest Posts Forums iShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Forums. 30 order I had out there for 2-3 weeks. Ceasing to be a substantial holder. Results of MeetingFor those curious about the T20 moves over the last 2 months of available data;Underlined = UnchangedGreen = Positive ChangeRed = Negative ChangeDYOR, not. Invex Granted Key European Patent for Exenatide, page-2. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. See page-34. . Target our investor community with our suite of Hotcopper Advertising. . ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Join the HotCopper ASX share market forum today for free. These are 2007 numbers. . Latest Posts. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. 026. 0. Discover historical prices for IXC. They'll still have 14-15M in cash plus ODD for TBI in Europe and soon, one from the FDA, with plans for a P2 TBI study. ASX - General. . Created with Sketch. ASX - Day Trading. Created with Sketch. Friday we moved 55% off 690k volume. Below is the broker data for IXC November to. My understanding is that NEU went from around $1. Created with Sketch. Target our investor community with our suite of Hotcopper Advertising opportunities. Expand. ASX - Day Trading. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. ASX - By Stock. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - General. A new thread to put trading comments / reasoning / opinions in. . . RAC went from 30 cents to $4 in the space of 5 months PAR went from 30 cents to $4 in the space of 1 and half years NEU went from $1. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. AdINVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC. Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Loading interactive chart. ASX - General. IXC Valuation Report MST. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. But there are two key factors that make me hope that the BoD pursues the Phase 2, but I worry that JP and co will push for the. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Notice of Investor Call and Presentation, page-2. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. Of course IXC isnt the stock market but its coincidental that selling has stopped around this 17 cents mark which aligns with the old trend line from back in the days. Given the quality of the posters on the IXC thread I am confident others will do the same. . Invex Receives Approval for Paediatric Plan from the EMA, page-3. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Slow and steady with IXC. 1950. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - By Stock. IXC below Example of that is NEU Investor Presentation, page-3. I'm thinking of flying there myself!Prof Alex Sinclair is to present in Melbourne and Sydney next. ASX - Short Term Trading. ASX - By Stock. 6 Upvote. Cold Comfort Ice Cream Company, Victoria, British Columbia. . . . 5 cents. IXC “ presented “ about the AGM time to who ? If the company is aware ( as others seem to think) of an individual seller then they need to be proactive and take them out . . , page-2. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. ASX - Day TradingCreated with Sketch. Market . My. ASX - Day TradingChange in substantial holding. Latest Posts. 0% $ODM 35. . With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. ASX - Day TradingAs thread states post your questions here and let’s start compiling a list. Created with Sketch. Created with Sketch. Join the HotCopper ASX share market forum today for free. . IXC Valuation Report MST. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. 1073084. ASX - Day Trading. , page-75. ASX - General. 38 was the valuation MST gave IXC 9 months ago Considering we are now even further de-risked, getting to the end result, wonder what MST valuation would be now. 59). Andrew Forrest , or his entities have been involved with IXC since inception. Loading. , page-3. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. 1. Although, IXC is trading about 3-4x lower than what I expect it to be. Bumping up this thread as $3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. . Share A few weeks ago in the lead up to the Phase 2 results invex included this slide on their slide deck - 'average 42 million increase in market cap after positive Phase 2 results'. Advertise. Last updated 15. Too many factors to make an educated appraisal of buyout pre-Phase 2 or post Phase 2. Notice of Annual General Meeting/Proxy FormInvex Receives Written Response from FDA on Type C MeetingNotification of cessation of securities - IXC. Yes its risky of course, like all the asx speculative stocks out there, but considering what NEU has done, what CUV has done (both billion dollar companies now), why wouldnt you. Created with Sketch. ASX - By Stock. P3 will be kicked off in early CY2021. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with. Trading HaltIXC Valuation Report MST. ASX - By Stock. ASX - By Stock. Forums. Forgot Client ID or Password? If you're a CommBank customer, you can access CommSec from Netbank. . *Close price adjusted for splits. ASX - By Stock. Share "Online registration will open 30 minutes before the Meeting. Quarterly Activities/Appendix 4C Cash Flow Report. Sentiment for Invex Therapeutics Ltd. Access the latest research articles and market investment insight for INVEX THERAPEUTICS LTD seamlessly. Market . Join the HotCopper ASX share market forum today for free. I'm doing my bit lolRecent success of NEU and ALA just goes to show there is money floating around, all IXC needs is a. Company has options because they have cash. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. Created with Sketch. ASX - General. , page-5. Discover historical prices for IXC. 20 to $7. com. Market Cap $16. Created with Sketch. ASX - By Stock. ASX - By Stock. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Market . . Fully funded. Cannot wait. British Columbia, Selkirk Mountains. Created with Sketch. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. ASX - Day Trading. Share. Both approaches can work, but it is not wise to confuse the two. ASX - General. . . Market open. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-2. 43 Sentiment: Buy Disclosure: Held. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Investor PresentationI would be worried about holding IXC if they had no more cash. A new thread to put trading comments / reasoning / opinions in. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. Lucky for you all IXC still sits at only 60 cents. 59pm 09/11/2023 ? HotCopper has news, discussion, prices and market data on INCITEC PIVOT LIMITED. ASX - By Stock. IXC (ASX) Ann: Trading Halt - HotCopper. sentiment based on opinions from HotCopper and others. 3¢. , page-5. ASX - General. ASX - By Stock. Created with Sketch. HotCopper has news, discussion, prices and market data on IXUP LIMITED. Report to HotCopper and itll be the end of it, cheers. Very impressive. Market open. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. . Global Phase 3 Trial of Presendin to Launch in Q4 2021Invex receives IND approvalInvex Receives Written Response from FDA on Type C Meeting, page-2. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. ASX - Day TradingQuarterly Activities/Appendix 4C Cash Flow ReportMarch 20 (Reuters) - Invex Therapeutics Ltd (IXC) : APPROVAL TO COMMENCE IIH EVOLVE PHASE III CLINICAL TRIAL RECEIVED FROM BUNDESINSTITUT FÜR. 147,415. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. ASX - By Stock. Hi Hot Copper, this will be a master thread for my daily posting of the Pharma Market Watchlist, please only keep commentary to the watchlist. Forums. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. 00% 21. Created with Sketch. 0¢ Sentiment: Buy Disclosure: Held. 0. ASX - Day TradingCreated with Sketch. Forums. , page-32. Created with Sketch. This was roughly 50/50 between lost wages and direct medical costs. is 19. , page-188. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. International Markets. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. The IXC stock may trade low due to this wider macroeconomic issues, but the business itself is top 5% to its peers merely from the fact of having no future funding requirements and that if the trial is a success having close to immediate revenues and default alive status via Peptron manufacturing contract fulfilling demand on potential FDA. ASX - By Stock. ASX - By Stock. Forums. Market . ASX - Day Trading. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. Advertise on HotCopper. 31% more bullish than other Healthcare sector stocks. . IXC Price at posting: 45. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . Trading HaltIXC Valuation Report MST. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. 7% #asx #ausbiz 23 Jun 2023 06:06:11Not been following IXC but it seems that this Orphan Drug Designation for TBI now have $0 value due to the other Phase III trial update and the company is. In 2005, IIH cost the American health care. 50%. Results are our big catalyst Other catalysts include: - new indication - directors buying - half way through trial (120 patients recruited) At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Orphan drug status. Forums. 7% #asx #ausbiz 23 Jun 2023 06:06:11. ASX - Day TradingInvex Files Pre-IND/Type B Meeting Request with US FDA, page-2. I think having this out we can discuss on the way. , page-4. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. 30 is a good sign as well. Charts. 1. . 0. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. 63%. Created with Sketch. . 0. Notification of cessation of securities - IXC. , page-2. Australian finance news, stock quotes, currency information and blogs Active Funds. Forums. Share Ok news not the greatest but I dont think its as bad as people gonna re-act (mainly retailers) Primary endpoint remains unchanged Protocol changes focus on reordering secondary endpoints - replacing PMD with the more. Forums. Created with Sketch. Created with Sketch. Latest Posts. 5mill options have been issued at a strike price of $1 First lot 250k to a soph. IXC has alot of catching up to do. ASX - Day Trading. . no point selling now. ASX - Day TradingIXC: 22/11/2023 1:08 PM : Notification of cessation of securities - IXC 4 pages 23. Met primary endpoints for phase 2 trials. . ASX - General. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Created with Sketch. Will management look for an early exit or are they wanting to take to market? Just came across IXC from another stock @JabraD posts on. Latest Posts. ASX - By Stock. ASX - By Stock. . Created with Sketch. Update - Notification regarding unquoted securities - IXC. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Below is the broker data for IXC November to. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. Last updated 10. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. ASX - By Stock. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. . Created with Sketch. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. ASX - Short Term Trading. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. Charts. 30 Haven’t supported share price since then on market . a shell trading below cash backing, ripe. 05. ASX - By Stock. ASX - Day TradingCreated with Sketch. 64440. Created with Sketch. I guess that's why retail performs so poorly on average, so many think they are long term investors but can't hold onto their shares for more. ASX - General. I see it at perhaps $5 prior to readout. . Some people like to gamble on stocks, others invest. Daily bounced well off support and now slowly creeping upId like to see a range develop now between say 18 - 23 before next bit of news, page-517. **Close price adjusted for splits and dividend and/or capital gain distributions. ASX - By Stock. ASX - By Stock. Share IXC needs to be proactive and release a statement. Created with Sketch. . . But the market volume was very low, which points to a lack of interest, the long horizons of biotech, lack of publicising or Notification of cessation of securities - IXC. Created with Sketch. 392 10/12/19 20:43 Post #: 41898691 Share @FullMoonFever Another chart request if you are up for it please thanks in advance IXC Valuation Report MST. LoginJoin Now. .